Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
Persistence of leukemic stem cells (LSC) after chemotherapy is thought to be responsible for relapse and prevents the curative treatment of acute myeloid leukemia (AML) patients. LSC and normal hematopoietic stem cells (HSC) share many characteristics and co-exist in the bone marrow of AML patients....
Saved in:
Main Authors: | Gerrit J Schuurhuis, Michael H Meel, Floris Wouters, Lisa A Min, Monique Terwijn, Nick A de Jonge, Angele Kelder, Alexander N Snel, Sonja Zweegman, Gert J Ossenkoppele, Linda Smit |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/afdfbec2f3a140adb7a2c8c49ec3e1ce |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness
by: Meaghan Boileau, et al.
Published: (2019) -
Suppression of Transposable Elements in Leukemic Stem Cells
by: Anthony R. Colombo, et al.
Published: (2017) -
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
by: Lars Velten, et al.
Published: (2021) -
Hematopoietic stem cell transplantation
by: Eleftheria Hatzimichael, et al.
Published: (2010) -
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
by: Donata Backhaus, et al.
Published: (2021)